| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.46 | 0.01 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |